39^th European Neurology Congress

Advances in Neurodegenerative Diseases

Advances in Neurodegenerative Diseases is a pivotal area of research that addresses complex disorders like Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis (ALS), all of which severely impact brain function and quality of life. Recent advances are providing hope by exploring disease mechanisms, innovative diagnostics, and groundbreaking treatments. Research has shed light on the role of protein misfolding and aggregation in neurodegenerative diseases, revealing key insights into how these proteins disrupt neural networks. Advanced imaging techniques, such as PET and MRI, now allow earlier detection of disease markers, enabling timely interventions. Additionally, breakthroughs in biomarkers, such as cerebrospinal fluid proteins and genetic profiling, offer promising avenues for more personalized treatments. Therapeutically, the development of disease-modifying drugs aims to slow progression rather than just alleviate symptoms. Novel approaches like gene therapy, CRISPR-based editing, and targeted monoclonal antibodies are under investigation, showing encouraging early results in clinical trials. Stem cell therapy is also making strides, with potential to regenerate damaged neural cells and restore functionality. These advances underscore a transformative era in neurodegenerative disease research. By focusing on underlying molecular mechanisms, clinicians and scientists are developing more targeted therapies that aim to improve patient outcomes and ultimately lead to cures for these debilitating conditions.